CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-01-30 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion | +14,262 | $9.31 | $133K | 251,827 |
| 2008-01-30 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion | +10,738 | $9.31 | $100K | 262,565 |
| 2008-01-30 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −10,738 | 0 | ||
| 2008-01-30 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −14,262 | 45,000 | ||
| 2008-01-25 | CRITCHFIELD GREGORY C President Myriad Genetic Labs | Exercise or conversion | +9,322 | $7.03 | $66K | 53,121 |
| 2008-01-25 | CRITCHFIELD GREGORY C President Myriad Genetic Labs | Exercise or conversion · Incentive Stock Option (right to buy) | −9,322 | 0 | ||
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −56 | $55.66 | $3K | 2,516 |
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −28 | $55.70 | $2K | 2,488 |
| 2007-02-06 | Evans James S Vice President Finance | Exercise or conversion | +5,626 | $5.13 | $29K | 24,026 |
| 2007-02-06 | Evans James S Vice President Finance | Sale | −5,626 | $37.00 | $208K | 18,400 |
| 2007-02-06 | Evans James S Vice President Finance | Exercise or conversion · Incentive Stock Option (right to buy) | −5,626 | 0 | ||
| 2006-11-16 | LANGER DENNIS Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2006-11-16 | ATTIYEH ROBERT S Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2006-11-16 | GILBERT WALTER PHD Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2006-11-16 | HENDERSON JOHN T Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2006-11-16 | WILSON LINDA S Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2006-11-15 | LANCHBURY JERRY S Executive V.P. - Research | Exercise or conversion | +4,176 | $12.54 | $52K | 4,176 |
| 2006-11-15 | LANCHBURY JERRY S Executive V.P. - Research | Sale | −4,176 | $29.00 | $121K | 0 |
| 2006-11-15 | LANCHBURY JERRY S Executive V.P. - Research | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,176 | 13,750 | ||
| 2006-11-10 | GILBERT WALTER PHD Director | Sale | −9,498 | $26.92 | $256K | 0 |
Page 33 of 35 · 689 trades